Valuations still count consider WAG $ 40 and PS of .50 to
RAD $ 1.56 .05 My Prediction to 2013 RAD to triple.
The Centers For Disease Control has reported heightened incidences of the flu in the U.S., including outpatient visits for flu-like symptoms at 4.6 percent, “above the national baseline of 2.2 percent,” according to the CDC’s report on week two (January 6-12).
In turn, everything from over-the-counter cough, cold and flu meds to thermometers and toothbrushes are flying off the shelves at drugstore chains, including the nation’s biggest one, as “this has been a more active flu season than we’ve seen in … years,” Jim Cohn, a Walgreens spokesman, told Forbes.
This trend will follow into February and March would you agree ?
Upgrades and refinancing and Raised guidance coming. We are going to have a much better quarter. Add on weakness.
Rite Aid commences debt refinancing transactions (RAD) 1.60 +0.04 : Co announced that it has commenced a series of debt refinancing transactions that would extend the maturity of a portion of Rite Aid's outstanding indebtedness and lower interest expense. The refinancing transactions are expected to include:
I'm looking for a sustainable trend RAD $ 1.38 is the way. Just off multi yr. loses and lows in stock price then beating the street and raising guidance. The flu shots are being sold out and this trend has just started and other support products are having the same demands. RAD is a gold mind and is working on refinancing a private equity group or insurance group or hospital group would do well to get RAD RAD is a great way to play on the new insurance rules. Rad valuations are just to compelling and a very big part to health care in the future front line demand. RAD is price at 1/10 it's peers WAG CVS they won't double in stock price but RAD will.
Check the charts, check the analyst upgrades, look at the increased volume and the money flow.